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INTRODUCTION
Sarcoidosis is a multisystem, granulomatous 
disease of unknown aetiology. Morphology 
of some granuloma types is characteristic of 
specific diseases so that this is basis for reach-
ing the final diagnosis. Therefore, this type of 
inflammation has been defined as specific. [1, 2, 
3]. Sarcoidosis belongs to the entities of specific 
inflammations, because of being characterized 
by inflammatory lesions, i.e. granulomas. The 
term “sarcoidosis” originates from the Greek 
word “sarkodes” meaning “fleshy” and suffix 
“-osis” meaning “condition” [1].
Sarcoidosis was described for the first time 
as a skin disease in 1877, in patients with multi-
ple purplish patches on the face and hands. 
Identical appearance of sarcoid granuloma can 
be seen regardless of the involved organ [1, 2, 
3]. Sarcoidosis mostly develops in younger and 
middle aged persons, predominantly women, in 
all geographic areas. It quite frequently occurs 
presenting severe clinical features in Afro-
Americans [1-5].
OBJECTIVE
The important aim of this study was to esti-
mate the role of pathology in the diagnosis and 
differential diagnosis of sarcoidosis and to point 
out the importance of establishing the diagnosis 
of sarcoidosis only in association of clinical with 
pathological studies. The purpose was to estab-
lish other conditions presenting with sarcoid 
granulomas and to estimate other conditions 
where hilar and mediastinal lymphadenopa-
thy could be the major symptom of the disease 
different from sarcoidosis.
METHODS
Out of the total number of 751 patients, 663 
biopsy positive sarcoidosis patients were 
analyzed in five-year period (1995–1999). 
Biopsy samples were obtained from different 
tissues and organs. All obtained tissue samples 
were routinely fixed and paraffin embedded 
and hematoxylin-eosin (H&E) stained [6]. The 
majority of the tissue samples were obtained 
by transbronchial and bronchial biopsy 
during bronchoscopy. Open lung biopsy was 
performed in patients when repeated bronchos-
copy did not resolve the etiology of the disease. 
Buffered formalin instillation with dispersion 
into the pulmonary parenchyma was made to 
distend alveolar spaces in their natural size and 
shape [6, 7]. Sarcoidosis was diagnosed by liver 
biopsy, splenectomy and skin biopsy.
SUMMARY
Introduction Sarcoidosis is a multisystem, granulomatous disease of unknown etiology. Sarcoid gran-
ulomas appear as immunological response to a particular but still unknown agent of the human body.
Objective The main purpose of this study was to point out the important fact that the exact diagno-
sis of sarcoidosis must be estimated by clinical and pathological correlation, and team cooperation 
between the clinician and the pathologist.
Methods Of 751 patients referred with the suspected diagnosis of sarcoidosis, from 1995 to1999, 663 
(431 female and 232 male) were analyzed and confirmed as having sarcoidosis stage I-III based on 
biopsy findings obtained by bronchoscopy, open lung biopsy, skin biopsy, liver biopsy or splenectomy.
Results Diagnosis of sarcoidosis was made in 663 patients, 431 females and 232 males (ratio 1.9:1). The 
average age of patients varied from 16 to 67 years, with those below age 50 years being predominant 
(78.4%). The highest number of patients was diagnosed in stage I of lung sarcoidosis (81.7%). Sarcoido-
sis was the most common cause of hilar and mediastinal lymphadenopathy (72.2%).
Conclusion Biopsy is a necessary diagnostic procedure for pathological diagnosis of sarcoid granu-
loma before treatment even in patients where clinical, radiological, biochemical and immunological 
tests imply the diagnosis of sarcoidosis.
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Acid-fast staining was performed to exclude or to detect 
the presence of acid-fast bacilli in granuloma in differential 
diagnosis to tuberculosis. Phospholipids within the capsule 
of bacilli were stained red and visible for microscopy.
Periodic Acid Schiff (PAS) staining was performed for 
distinction of fibrinous necrosis in sarcoidosis from other 
types of necrosis. Fibrinous necrosis was stained as a clear 
and lightly red tiny granular mass [7, 8].
Peripheral fibrosis and hyalinization around granulo-
mas was stained by silver impregnation of fibrous fibres.
RESULTS
Sarcoidosis was confirmed in 431 female and 232 male 
patients, in total ratio 1. 9:1. The predominant number 
of patients (78.4%) was aged below 50 years, with a peak 
between 41-50 years (Table 1). The youngest patient was 
a 16-year old girl. The oldest one was a 67-year old man.
Sarcoidosis was most frequently diagnosed in I stage of 
lung disease by transbronchial biopsy and rarely in II or 
III stage of lung disease by transbronchial and bronchial 
biopsy (Table 2).
By liver biopsy and splenectomy the diagnosis of 
sarcoidosis was confirmed in six patients, also by skin 
biopsy in six patients. In nine patients the diagnosis of 
sarcoidosis was established by open lung biopsy.
Sarcoidosis was the leading cause of hilar and medi-
astinal lymphadenopathy in 72.2% of our patients (Table 
3). The diagnosis was made by transbronchial biopsy. 
Metastatic deposits in lymph node tissue of malignant 
tumours of other organs were diagnosed also by trans-
bronchial biopsy. The origin of metastasis was accurate 
as confirmed by immunophenotipization. Mediastinal 
lymphomas, mostly of Hodgkin type, in 13 patients (1.8%) 
were the cause of lymphadenopathy.
Tuberculosis was diagnosed in four patients in whom 
acid-fast bacilli in caseating granulomas was detected.
DISCUSSION
Sarcoidosis is a specific granulomatous disease. It is still a 
question weather sarcoidosis is a syndrome or an entity [9].
Sarcoidosis can be diagnosed in all ages, but predomi-
nantly in young and middle aged persons of both genders, 
but frequently in women, in all parts of the world and in 
all races. The incidence is quite high in the Scandinavi-
ans. Sarcoidosis is almost unknown disease in South-East 
Asia and China [4].
Due to the clinical course of sarcoidosis, spontane-
ous remission is possible. Most often sarcoidosis patients 
develop symptoms like dry cough, short breath and arthral-
gia. There are indications that the disease is hereditary 
[1, 4].
According to the chest radiological findings sarcoidosis 
is classified in 4 stages: stage 0 – regular chest X-ray; stage I 
– hilar and mediastinal lymphadenopathy; stage II – hilar 
and mediastinal lymphadenopathy accompanied with infil-
trates in pulmonary parenchyma; stage III – pulmonary 
infiltrates without hilar and mediastinal lymphadenopa-
thy, with frequent formation of the so-called ground glass 
effect; stage IV – pulmonary fibrosis [10, 11].
A typical morphological pattern of sarcoidosis is nonca-
seating granuloma appearing after accumulation of mono-
nuclear inflammatory cells in involved tissue. Accumula-
tion of macrophages transformed to epitheloid cells are 
surrounded mostly by T cell population of lymphocytes. 
It is presumed that prolonged antigen stimulation leads 
to transformation of macrophages to epitheloid cells and 
appearance of giant, multinuclear cells, specifically of Lang-
hans type [6].
By electron microscopy two types of epitheloid cells are 
estimated, the first one with the developed endoplasmatic 
reticulum with a few vacuoles and granules and the second 
one with a lot of fine granular material. Cytoplasm of epith-
eloid cells contains enormous amount of dipeptile carboxy-
dase enzyme (angiotensin-converting enzyme), so that 
these cells are responsible for the increasing level of this 
enzyme in blood serum. The epitheloid cells are special-
ized for extra cellular secretion, not for phagocytosis [7].
Giant, multinuclear cells arise in fusion of two or 
more macrophages. Numerous nuclei are pressed to cell 
membrane, looking as sickle-like or half-moon shaped 
nuclei (Langhans type cell) or chaotically “thrown” all 
the way through cell cytoplasm. Sometimes the nuclei are 
“pushed away” by the Schaumann body. Characteristic 
cytoplasmatic inclusions are sometimes present, but are not 
typical only for giant multinuclear cells in sarcoid granu-
loma. They are asteroid and Schaumann bodies. Asteroid 
bodies are lipoprotein and acidophilic star shaped inclu-
Table 1. Age of patients with sarcoidosis
Age (years) Number of patients
≤30 148 (22.4%)
31–40 162 (24.5%)
41–50 210 (31.5%)
51–60 117 (17.7%)
≥61 26 (3.9%)
Total 663 (100%)
Table 2. Histological diagnosis of pulmonary sarcoidosis classified by 
stages
Stage of pulmonary sarcoidosis Number of patients
I5 4 2  ( 8 1 . 7 % )
II 100 (15.1%)
III 21 (3.2%)
Total 663 (100%)
Table 3. Differential diagnosis: causes of hilar and mediastinal lympha-
denopathy
Differential diagnosis Number of patients
Pulmonary sarcoidosis – stage I 542 (72.2%)
Reactive lymphadenopathy 160 (21.3%)
Metastasis of other malignant tumours 32 (4.2%)
Lymphoma 13 (1.8%)
Tuberculosis 4 (0.5%)
Total 751 (100%)483
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sions. They present amorphic material arising from micro-
filaments, microtubules, mature and immature centrioles. 
The Schaumann bodies contain protein matrix impreg-
nated with iron and calcium salts in concentric lamellas 
and crystals capable for light polarization. This inclusion 
is formed in epitheloid giant cells or extracellularly, near 
the peripheral sinus. The granular endoplasmatic retic-
ulum is weakly developed in giant cells. Mitochondria 
and lysosomes show degenerative changes and cytoplasm 
contains numerous vesicles and different particles [7].
Among epitheloid cell CD4+ lymphocytes and CD8+ 
lymphocytes are found peripherally. In bronchoalveo-
lar lavage the number of CD4+ lymphocytes is increased 
compared to CD8+ lymphocytes. A fibrous rim develops 
around the granuloma spreading to its centre. It is a sign 
of progression of sarcoidosis and the beginning of the 
scar arising in the parenchyma probably causing organ’s 
dysfunction and insufficiency. Sometimes granulomas are 
similar to those in hypersensitive pneumonitis [7, 10, 11].
 Necrotizing sarcoid granulomas are described in the 
literature. They involve pulmonary parenchyma exclu-
sively and are characterized by fibrinous and coagulate 
necrosis in the central zone of granuloma, without the 
presence of acid-fast bacilli. Necrosis is clearly red stained 
by PAS. Necrotizing sarcoid granulomas are the result of 
vasculitis. Giant cells are more numerous around the 
necrosis than in sarcoid granulomas. Epitheloid cells are 
also increased in this type of granuloma. There is no fibro-
sis and hyalinization around necrotizing sarcoid granulo-
mas. These granulomas resolve after cytostatic and ster-
oid therapy [10].
Differential diagnosis from other granulomas due to 
their morphology pattern is relatively easy, particularly 
by open lung biopsy .Pulmonary parenchyma changes are 
mostly bilateral reticular and reticulonodular infiltrates 
less than 1cm in size, accompanied with emphysema and 
“honey comb” lungs. Pleural effusion appears in sarcoido-
sis very rarely [11, 12]. Sarcoid granulomas are grouped 
within the parenchyma of the lungs. They can be conflu-
ent or non-confluent, separated by fibrous or hyaline thick-
ened septa, and distributed peribronhiolarly, perivascularly, 
interlobularly or under the pleura. Emphysema or even the 
“honey comb” pattern can be present in the surrounding 
pulmonary parenchyma [11, 13, 14].
Stage I of pulmonary sarcoidosis is lymphadenopathy, 
manifested in hilar and mediastinal lymph nodes enlarge-
ment. This stage of the lung disease is diagnosed most 
frequently, in about 90% of patients. The lymph nodes 
enlarged size increase from 20mm to 30mm causing dry 
cough and sensation of the tightness in the chest, but the 
patient may also be without any of the symptoms. In the 
lymph node parenchyma numerous, mostly confluent and 
no confluent granulomas, with or without giant cells are 
present. Uninvolved lymph node parenchyma is without 
active follicles [7, 8].
Some conditions (berylliosis), different substances (talc) 
and lymphomas provoke a lymph node reaction, remaining 
on sarcoid granulomas [15]. So, they are called sarcoid-like 
reaction, sarcoid-type reaction or sarcoid-related granu-
lomas. Mostly, they arise in lymph nodes draining organs 
involved by tumour, called lymph node draining carcino-
mas. Most frequently they appear in draining lymph nodes 
in carcinoid tumours, lung and breast cancer and testicu-
lar tumours [16, 17].
Vasculitis and systemic fibrous tissue disease, even HIV 
infection of lymph nodes may provoke a sarcoid reaction. 
This condition also arises in pulmonary tissues as a sign 
of rejection after lung transplantation. The sarcoid-related 
reaction arises as a morphological pattern of post-irradi-
ation pneumonitis with the presence of numerous non-
caseating granulomas, surrounded by fibrous tissue. In 
the sarcoid-like reaction lymph nodes may be increased 
in measure and in morphology similar to sarcoidosis, so 
the proper diagnosis is difficult to obtain [6, 8].
Cervical lymph nodes are enlarged in sarcoidosis, as well 
as in lymphoma. Hodgkin’s lymphoma and sarcoidosis arise 
in younger persons. Almost always Hodgkin’s lymphoma is 
manifested as neck, hilar and mediastinal lymphadenopa-
thy, as well as sarcoidosis [8, 16, 17].
In cases of hilar and mediastinal lymphadenopathy 
pathological diagnosis of accidentally detected metastasis 
may not be a surprise. Tumour origin may be from close 
(lung and breast carcinoma) or distant (intestinal carci-
noma) organs [11, 12].
Sarcoidosis often involves skin, eye, liver, spleen, heart, 
bone marrow, salivary glands, muscles and nervous system 
[1, 13, 15].
Skin sarcoidosis arises in about 75% of patients with 
the diagnosis of pulmonary sarcoidosis. Granulomas are 
often commonly called Boeck sarcoids, arising in the derm 
and rarely in the hypoderm. They are manifested as soft 
multiple purplish patches or nodules. Numerous conflu-
ent or non-confluent granulomas without necrosis form 
a skin lesion. Older granulomas contain a high number 
of giant multinuclear cells and intra-cytoplasmatic inclu-
sions. Around the edges of the granuloma there is only a 
small number of lymphocytes and a rim of dense fibres 
[3, 13, 14].
Skin changes often occur associated with sarcoidosis, 
most frequently erythema nodosum. It is localized in the 
hypoderm manifested as painful red or livid nodules. A 
non-specific inflammation is histological presentation [1, 
13, 14].
Ocular involvement can occur inpatients with sarcoido-
sis, but the most frequent site is the uvea and iris, cusing 
regional inflammation, glaucoma or blindness. Lachrymal 
and parotid glands may be involved by sarcoidosis at the 
same time [3, 13, 14].
The spleen is involved in approximately 75% of patients 
with pulmonary sarcoidosis, although real splenomegaly is 
present in about 20%. Sarcoid granulomas are only visible 
when granulomas are confluent. Numerous tiny granulo-
mas, cellular or hyaline, are diffusely distributed mostly in 
the white pulp [15, 18, 19].
The liver is also involved but rarely enlarged. Sarcoid 
granulomas are mostly localized in the portal space, less 
frequently in the liver acinus. The sarcoid granulomas can 
be diagnosed by needle biopsy of liver parenchyma [18, 19].484
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Numerous granulomas are seen in the bone marrow 
with resorption of bone cortex. Hands and feet are most 
frequently involved [3, 13, 20, 21].
CONCLUSION
Sarcoidosis is a multisystem disease, with predominance 
in young persons. Radiological finding of mediastinal and 
hilar lymphadenopathy is the most frequent sign of pulmo-
nary sarcoidosis. In this stage of the lung disease trans-
bronchial biopsy is most suitable to confirm sarcoido-
sis, but the unexpected diagnosis as lymphoma, meta-
static tumour, tuberculosis and reactive lesions could be 
possible.
By routine microscopic examination, diagnosis of epith-
eloid granulomas, containing varies numbers of giant, 
multinuclear cells with or without fibrosis and hyaliniza-
tion, the diagnosis of sarcoidosis is confirmed. Morpholog-
ical appearance of sarcoid granuloma is the same despite 
of the involved organ.
In patients, even when typically clinical, radiological, 
biochemical and immunological results clearly point to 
sarcoidosis, biopsy is necessary to confirm the diagnosis.
REFERENCES
1.  Stopsarcoidosis [homepage on the Internet]. Chicago: Foundation 
for Sarcoidosis Research; c2010. General Info; [about 2 screens]. 
Available from; http://www.stopsarcoidosis.org/sarcoidosis/
diseasefacts.htm.
2.  Sharma OP. Murray Kornfeld, American College of Chest Physicians, 
and sarcoidosis: a historical footnote: 2004 Murray Kornfeld 
Memorial Founders Lecture. Chest. 2005; 128:1830-5.
3.  Judson MA. The etiologic agent of sarcoidosis: What if there isn’t 
one? Chest. 2003; 124:6-8.
4.  Demedts M, Wells AU, Antó JM, Costabel U, Hubbard R, Cullinan P, 
et al. Interstitial lung diseases: an epidemiological overview. Eur 
Respir J. 2001; 18:2S-16S.
5.  Hosoda Y, Sasagawa S, Yamaguchi T. Sarcoidosis and tuberculosis: 
epidemiological similarities and dissimilarities. Sarcoid Vasc Diffuse 
Lung Dis. 2004; 21:85-93.
6.  Thomas BC, Carrington BC. Infiltrative lung disease. In: Thurlbeck 
MW. Pathology of the Lung. New York: Thieme Medical Publishers, 
Inc; Stuttgart: Georg Thieme Verlag; 1988. p.425-519.
7.  Ioachim HA. Sarcoidosis lymphadenopathy. In: Ioachim HA, Ratech 
H. Ioachim’s Lymph Node Pathology. 3rd ed. Philadelphia: 
Lippincott Williams & Wilkins; 2002. p.223-33.
8.  Stansfeld AG. Inflammatory and Reactive Disorders. In: 
Morphological Interpretation of Lymph Nodes. Philadelphia: J. B. 
Lippincott Company; 1995. p.128-30.
9.  Reich JM. What is sarcoidosis? Chest. 2003; 124:367-71.
10.  Charles K, Frederic BA. Lung and mediastinum. Sarcoidosis. In: 
Kissane MJ. Anderson’s Pathology. 9th ed. New York: C. V. Mosby 
Company; 1990. p.978-81.
11.  Trisolini R, Agli LL, Cancellieri A, Poletti V, Tinelli C, Baruzzi G, et al. 
The value of flexible transbronchial needle aspiration in the 
diagnosis of stage I sarcoidosis Chest. 2003; 124:2126-30.
12.  Wildi SM, Judson MA, Fraig M, Fickling WE, Schmulewitz N, 
Varadarajulu S, et al. Is endosonography guided fine needle 
aspiration (EUS-FNA) for sarcoidosis as good as we think? Thorax. 
2004; 59:794-9.
13.  White ES, Lynch JP. Sarcoidosis involving multiple systems 
diagnostic and therapeutic challenges. Chest. 2001; 119:1593-7.
14.  Statement on Sarcoidosis: Joint Statement of the American 
Thoracic Society (ATS), the European Respiratory Society (ERS) and 
the World Association of Sarcoidosis and Other Granulomatous 
Disorders (WASOG) adopted by the ATS Board of Directors and by 
the ERS Executive Committee, February 1999. Am J Respir Crit Care 
Med. 1999; 160:736-55.
15.  Vucinic-Mihailovic V, Sharma OP. Atlas of Sarcoidosis: Pathogenesis, 
Diagnosis and Clinical Features. London: Springer-Verlag; 2005. 
p.9-15.
16.  Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Association of 
malignancy with diseases causing interstitial pulmonary changes. 
Chest. 2002; 121:1278-89.
17.  Okada K, Sasaki M, Nanjo H, Ito M, Takahashi S, Itoi E. Benign lesions 
in cancer patients unusual association of osteosarcoma and 
sarcoidosis. J Clin Oncol. 2005; 23(3):641-3.
18.  Škodrić-Trifunovć V, Vučinić V, Čolović R, Videnović J, Žugić V, Stojšić 
J. Dijagnostički postupci u otkrivanju sarkoidoze jetre i slezine. Med 
Pregl. 2004; 57(9-10):462-6.
19.  Warshauser DM, Lee JKT. Imaging manifestations of abdominal 
sarcoidosis. AJR. 2004; 182:15-28.
20.  Sharma OP, Mihailovic-Vucinic V. Clinical features and treatment of 
bone sarcoidosis. CPD Rheumatology. 2001; 2:40-7.
21.  Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. 
Radiologic manifestations of sarcoidosis in various organs. 
Radiographics. 2004; 24:87-104.485
www.srp-arh.rs
Srp Arh Celok Lek. 2011;139(7-8):481-485
КРАТАК САДРЖАЈ
Увод  С а р  к о  и  д о  з а   ј е   м у л  т и  с и  с т е м  с к о,   г р а  н у  л о  м а  т о  з н о   о б о -
љ е  њ е   н е  п о  з н а  т е   е т и  о  л о  г и  ј е .   С а р  к о  и д  н и   г р а  н у  л о  м и   н а  с т а -
ју  као  имун ски  од го вор  на  од ре ђе ни,  али  још  не по зна ти, 
агенс  у  ор га ни зму.
Циљ ра да Циљ истраживања био је да се ука же на ва жну чи-
њ е  н и  ц у   д а   с е   д и  ј а г  н о  з а   с а р  к о  и  д о  з е   п о  с т а  в љ а   ј е  д и  н о   у   к л и -
н и ч  к о - п а  т о  л о  ш к о ј   к о  р е  л а  ц и  ј и ,   с а  р а д  њ о м   к л и  н и  ч а  р а   и   п а -
то ло га.
М е  т о  д е  р а  д а  Од укуп но 751 бо ле сни ка за ко јег се сум ња ло 
да бо лу је од сар ко и до зе, ана ли зи ра на су 663 (431 же на и 232 
му шка р ца) код ко јих је то ком пе то го ди шњег пе ри о да по ста-
в љ е  н а  д и  ј а г  н о  з а  с в а  т р и  с т а  д и  ј у  м а  о в о г  о б о  љ е  њ а .  Д и  ј а г  н о -
з а   б о  л е  с т и   п о  с т а  в љ е  н а   ј е   н а   о с н о  в у   б и  о п  т и ч  к о г   м а  т е  р и  ј а -
л а   д о  б и  ј е  н о г   т о  к о м   б р о н  х о  с к о  п и  ј е ,   н а  л а  з а   х и  р у р  ш к е   б и  о п -
си је  плу ћа,  би оп си је  ко же  и  би оп си је  је тре,  као  и  на  осно ву 
с п л е  н е к  т о  м и  ј е   у с л е д   с п л е  н о  м е  г а  л и  ј е   н е  п о  з н а  т о г   п о  р е  к л а .
Ре зул та ти Од  нос обо  ле  лих же  на и му  шка  ра  ца био је 1,9:1. 
Б о  л е  с н и  ц и   с у   и м а  л и   и з  м е  ђ у   16   и   67   г о  д и  н а .   В е  ћ и  н а   б о  л е -
сни  ка (78,4%) би  ла је ста  ра до пе  де  сет го  ди  на. Код нај  ве  ћег 
б р о  ј а  и с  п и  т а  н и  к а  у с т а  н о  в љ е н  ј е  п р  в и  с т а  д и  ј у м  п л у ћ  н е  с а р -
к о  и  д о  з е   (81, 7 %).   С а р  к о  и  д о  з а   ј е   б и  л а   н а ј ч е  ш ћ и   у з р о к   х и  л а р -
н е   и   м е  д и  ј а  с т и  н а л  н е   л и м  ф а  д е  н о  п а  т и  ј е   ( 7 2 , 2 %).
За кљу чак Па ци јен те код ко јих кли нич ки, би о хе миј ски и иму-
н о  л о  ш к и  т е  с т о  в и  ј а  с н о  п о  к а  ж у  д а  б о  л у  ј у  о д  с а р  к о  и  д о  з е  п о -
треб но је оба ве зно под врг ну ти би оп си ји и па то хи сто ло шкој 
д и  ј а г  н о  с т и  ц и  у з о р  к а  у з е  т о г  т к и  в а  п р е  з а  п о  ч и  њ а  њ а  л е  ч е  њ а .
Кључ не  ре чи:  г р а  н у  л о  м а  т о  з н о   о б о  љ е  њ е ;   м е  д и  ј а  с т и  н а л  н а  
л и м  ф а  д е  н о  п а  т и  ј а ;   д и  ј а г  н о  с т и  к а
Патохистолошка и диференцијална дијагностика плућне и 
ванплућне саркоидозе
Јелена Стојшић1, Виолета Вучинић-Михаиловић2, Драгана Јовановић2, Мира Стојковић3, 
Јелица Виденовић-Иванов2, Снежана Филиповић2
1Одељење торакопулмоналне патологије, Служба за патохистологију, Клинички центар Србије, Београд, Србија;
2Клиника за пулмологију, Клинички центар Србије, Београд, Србија;
3Клиника за гастроентерологију, Клинички центар Србије, Београд, Србија
Примљен • Received: 12/04/2010  Прихваћен • Accepted: 21/05/2010